Symposium on Targeted Protein Degradation
Janssen organizes a Targeted Protein Degradation symposium in Beerse, Belgium, on September 29, 2022. Targeted Protein Degradation is an innovative technology that is changing the drug discovery landscape. This technology opens exciting opportunities to modulate clinically relevant targets that are currently considered inaccessible by conventional modalities, such as inhibitory small molecules and antibodies.
Let's gather to talk about cutting-edge research on the promising potential of this novel therapeutic approach.
Take part and gain insight into cutting-edge research on the promising potential of protein degraders. Speakers include Dario Alessi and Alessio Ciulli (University of Dundee), Nicolas Thomä (Friedrich Miescher Institute for Biomedical Research), Stefan Knapp (Goethe-Universität), Rajesh Chopra (Apple Tree Partners), Phil Chamberlain (Neomorph), Manfred Koegl (Boehringer Ingelheim), Matthias Brand (Proxygen), Zachary Carpenter (VANTAI), Christian Dillon (Proteini) and Jennifer Venable (Janssen Research & Development). Kurt Pike from Johnson & Johnson Innovation will lead an innovation session on this topic.
Check out the full program here.
